Compare Amphastar Pharmaceuticals Inc (AMPH) vs Eaton Corporation plc (ETN) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Eaton (ETN) trades at $407.28, up 0.36% today, with a neutral technical stance and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $2.81 surpassing the $2.73 estimate. Fundamentals remain robust with a 36.89% gross margin and 20.87% ROE, though valuation multiples like the 39.85 P/E are elevated. Recent news highlights expansion in energy infrastructure and sustainability investments.

Outlook is positive given analyst consensus targets near $449.50 and zero sell ratings, but risks include high valuation sensitivity and projected 2026 cash flow pressure from increased investing activity. The stock offers growth exposure to power management and AI infrastructure trends, balanced by execution risks in a competitive industrial sector.